Post-Bypass Hypotension After Septal Myectomy: Which Pressor Doesn't Reopen the Obstruction
A 52-year-old woman with hypertrophic obstructive cardiomyopathy is hypotensive coming off bypass after septal myectomy. Every vasopressor in the cart works by a different mechanism, and only one of those mechanisms is guaranteed not to recreate the exact obstruction the surgery just relieved.
Priya M., a 52-year-old woman, taught middle school choir for two decades before shortness of breath on the stairs to her classroom forced her into a cardiology workup last year that found hypertrophic obstructive cardiomyopathy — a resting LVOT gradient of 78mmHg that climbed past 110 with Valsalva, refractory to maximal doses of metoprolol and disopyramide. Septal myectomy was scheduled after her third syncopal episode, this one while conducting a rehearsal, made the risk of continued medical management harder to justify than the surgery itself. Both drugs were held the morning of surgery, which matters for what follows: the negative inotropy that had been holding her gradient down all year is no longer on board.
The procedure went as planned — the surgeon resected roughly eight grams of septal muscle, and intraoperative TEE confirmed the resting gradient had fallen from 78mmHg to 6mmHg before she ever left the table. That number is the most useful thing the team has, because it means the obstruction she came in with is genuinely gone and any hypotension now is not simply her old physiology reasserting itself. Coming off cardiopulmonary bypass, though, her blood pressure will not hold: mean arterial pressure sitting in the low 50s despite an initial phenylephrine bolus, heart rate 88 in sinus rhythm, and a repeat TEE view the team is now waiting on to see what is happening rather than guess. A rate of 88 is worth noticing in a ventricle this thick — it shortens diastolic filling in a chamber that depends on filling more than most, so part of what looks like a resistance problem may be a filling problem she can no longer compensate for. The stakes of guessing wrong are specific and immediate: the surgery just spent an hour widening her outflow tract, and the wrong vasopressor choice — anything that adds inotropy or chronotropy — could recreate the same dynamic obstruction from the operating table she came in to have fixed, undoing the resection before she is even extubated.
Off bypass, pressure not holding
More phenylephrine. Pure alpha agonism is the correct first move here regardless of what the repeat TEE shows — raising afterload increases ventricular volume and reduces the pressure gradient across the outflow tract. It's the textbook answer in HOCM, and nothing about coming off bypass changes that physiology.
She's already had a phenylephrine bolus and her pressure hasn't held. That's not nothing — alpha receptors are commonly relatively desensitized right off bypass, and I've watched phenylephrine doses climb with diminishing effect in exactly this window more times than I can count. I'd move to vasopressin now rather than keep escalating a drug that may already be losing efficacy.
Vasopressin still carries no inotropic or chronotropic effect — it works through V1 receptors, a mechanistically separate pathway from the desensitized alpha-1 receptors phenylephrine depends on. It shouldn't recreate the gradient any more than phenylephrine would, and it may actually work.
Both of you are treating this as settled vasoplegia, but the repeat TEE just came up and I don't think it's that simple — there's mild global hypokinesis that wasn't there on the pre-bypass view, not just a resolved gradient with low resistance. That doesn't rule out vasoplegia, but it raises a real possibility this is at least partly a contractility problem from manipulation near the septum during the resection.
If that's true, a purely alpha-selective agent could leave a genuine low-output state undertreated while we chase a blood pressure number. I'm not arguing for a full inotrope — I agree that's the wrong direction given the LVOT physiology — but I want low-dose norepinephrine on the table specifically because its modest beta-1 effect may be exactly the support she needs, not a risk we're avoiding for no reason.
Agreed: vasopressin started, phenylephrine not escalated further, milrinone explicitly excluded from consideration regardless of what further imaging shows. Repeat TEE ordered at fifteen minutes to reassess contractility before deciding on norepinephrine.
Not agreed at handoff: whether the mild hypokinesis on the repeat view will resolve on its own as bypass effects wear off, or represents a real transient contractility deficit warranting low-dose norepinephrine. The second anesthesiologist's position — that this possibility deserved a name and a contingency plan rather than being folded into a generic "give more vasopressin" default — was accepted by both other voices as the right posture without either committing to starting norepinephrine yet.